dipyridamole has been researched along with Dermatitis Medicamentosa in 3 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zeng, W | 1 |
Glassman, S | 1 |
Dalipaj, M | 1 |
Ruddy, T | 1 |
Salava, A | 1 |
Alanko, K | 1 |
Hyry, H | 1 |
Jones, L | 1 |
Griffin, S | 1 |
Palmer, S | 1 |
Main, C | 1 |
Orton, V | 1 |
Sculpher, M | 1 |
Sudlow, C | 1 |
Henderson, R | 1 |
Hawkins, N | 1 |
Riemsma, R | 1 |
1 review available for dipyridamole and Dermatitis Medicamentosa
Article | Year |
---|---|
Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.
Topics: Aspirin; Clopidogrel; Cost-Benefit Analysis; Delayed-Action Preparations; Diarrhea; Dipyridamole; Dr | 2004 |
2 other studies available for dipyridamole and Dermatitis Medicamentosa
Article | Year |
---|---|
Cutaneous drug eruption from aminophylline use during dipyridamole nuclear stress testing.
Topics: Aged; Aminophylline; Dipyridamole; Drug Eruptions; Exercise Test; Female; Humans | 2010 |
Dipyridamole-induced eczematous drug eruption with positive patch test reaction.
Topics: Cerebral Infarction; Dipyridamole; Drug Eruptions; Humans; Hypersensitivity, Delayed; Male; Middle A | 2012 |